IDT Australia Ltd (ASX: IDT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
IDT Australia Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
IDT Australia Ltd (ASX: IDT)
Latest News

Healthcare Shares
How did ASX biotech shares perform in FY22?

Healthcare Shares
Why the IDT Australia (ASX:IDT) share price is crashing 37% lower today

Healthcare Shares
Why is the IDT (ASX:IDT) share price halted today?

Healthcare Shares
IDT (ASX:IDT) share price swings as CEO lauds mRNA tech in fight against Omicron

Share Market News
The Starpharma (ASX: SPL) share price surges on Vietnam launch

Healthcare Shares
IDT Australia (ASX:IDT) share price rockets 40% on COVID vaccine update

Share Gainers
Here's why the IDT Australia (ASX:IDT) share price is up 75% in a month.

Share Gainers
IDT Australia (ASX: IDT) share price surges 16% on vaccine government talks

Healthcare Shares
Why the IDT (ASX:IDT) share price is rocketing 25% on Wednesday

Share Gainers
Why the IDT Australia (ASX:IDT) share price is storming 19% higher today

Share Gainers
Why the IDT Australia (ASX:IDT) share price is up 150% in just 2 days

Share Market News
Why COVID-19 is launching the IDT Australia (ASX:IDT) share price 65%
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
08 May 2006 | $0.0350 | 100.00% | Interim | 26 May 2006 |
30 Sep 2005 | $0.0450 | 100.00% | Final | 21 Oct 2005 |
08 Apr 2004 | $0.0300 | 100.00% | Interim | 30 Apr 2004 |
IDT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About IDT Australia Ltd
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.
IDT Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
08 Dec 2023 | $0.10 | $0.00 | 0.00% | 63,857 | $0.10 | $0.11 | $0.10 |
07 Dec 2023 | $0.11 | $0.00 | 0.00% | 29,785 | $0.10 | $0.11 | $0.10 |
06 Dec 2023 | $0.10 | $0.00 | 0.00% | 80,848 | $0.11 | $0.11 | $0.10 |
05 Dec 2023 | $0.11 | $0.00 | 0.00% | 448,484 | $0.11 | $0.11 | $0.11 |
04 Dec 2023 | $0.11 | $-0.01 | -9.09% | 82,380 | $0.11 | $0.11 | $0.11 |
01 Dec 2023 | $0.11 | $0.00 | 0.00% | 34,503 | $0.11 | $0.11 | $0.11 |
30 Nov 2023 | $0.11 | $0.01 | 9.52% | 484,999 | $0.11 | $0.12 | $0.11 |
29 Nov 2023 | $0.11 | $0.00 | 0.00% | 362,521 | $0.10 | $0.11 | $0.10 |
28 Nov 2023 | $0.10 | $0.00 | 0.00% | 173,951 | $0.11 | $0.11 | $0.10 |
27 Nov 2023 | $0.10 | $0.00 | 0.00% | 1,941,611 | $0.10 | $0.13 | $0.10 |
24 Nov 2023 | $0.09 | $0.00 | 0.00% | 861,457 | $0.09 | $0.10 | $0.09 |
23 Nov 2023 | $0.09 | $0.01 | 12.50% | 414,270 | $0.08 | $0.09 | $0.08 |
22 Nov 2023 | $0.08 | $-0.01 | -11.76% | 54,126 | $0.08 | $0.08 | $0.08 |
21 Nov 2023 | $0.09 | $0.00 | 0.00% | 24,162 | $0.09 | $0.09 | $0.08 |
20 Nov 2023 | $0.09 | $0.00 | 0.00% | 300,000 | $0.09 | $0.09 | $0.09 |
17 Nov 2023 | $0.09 | $0.00 | 0.00% | 403,918 | $0.09 | $0.09 | $0.08 |
16 Nov 2023 | $0.09 | $0.01 | 12.50% | 325,905 | $0.08 | $0.09 | $0.08 |
15 Nov 2023 | $0.08 | $0.00 | 0.00% | 38,560 | $0.08 | $0.08 | $0.08 |
14 Nov 2023 | $0.08 | $0.00 | 0.00% | 621,426 | $0.08 | $0.08 | $0.08 |
13 Nov 2023 | $0.08 | $0.01 | 12.82% | 19,748 | $0.08 | $0.08 | $0.08 |
10 Nov 2023 | $0.08 | $0.00 | 0.00% | 138,800 | $0.08 | $0.08 | $0.08 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
07 Aug 2023 | Mark Simari | Issued | 6,000,000 | $390,000 |
Issue of options.
|
07 Aug 2023 | Geoffrey Sam | Issued | 3,000,000 | $195,000 |
Issue of options.
|
07 Aug 2023 | Jane Ryan | Issued | 3,000,000 | $195,000 |
Issue of options.
|
21 Jul 2023 | Mark Simari | Buy | 230,770 | $15,000 |
Participation in share purchase plan.
|
21 Jul 2023 | Geoffrey Sam | Buy | 461,539 | $30,000 |
Participation in share purchase plan.
|
04 May 2023 | Mark Simari | Transfer | 355,206 | $22,378 |
Off-market transfer.
|
04 May 2023 | Geoffrey Sam | Transfer | 355,206 | $22,378 |
Off-market transfer.
|
04 May 2023 | Jane Ryan | Transfer | 79,366 | $5,000 |
Off-market transfer.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Mark Anthony Simari | Non-Executive Director | Oct 2022 |
Mr Simari is an experienced professional in the health industry and has over 15 years of Board experience in a diverse range of organisations. He was instrumental in Paragon Care becoming one of the largest independent healthcare suppliers in the Australian and New Zealand Markets, creating a healthcare platform spanning across capital equipment, consumables, devices and service and maintenance. He is Executive Director of Careteq Limited and Non-Executive Director of Tali Digital Limited and also a chairman of risk committee.
|
Mr Geoffrey Joseph Sam | Non-Executive Director | Oct 2022 |
Mr Sam has held previous independent Non-executive Board positions with listed companies Money 3 Ltd, Hutchinsons Childcare Services Ltd and was Managing Director of Nova Health Ltd. He is the Co-Founder and Board member of Healthe Care Australia Pty Ltd, a privately owned health care company comprising a portfolio of 18 hospitals. He is Non-Executive Director of Earlypay Ltd, Paragon Care Ltd and Change Financial Ltd. He is member of risk committee.
|
Dr Jane Ryan | Non-Executive Director | Jan 2022 |
Dr Ryan has over 30 years of international experience in the pharmaceutical and biotechnology industries where she has held executive roles in management of research and development programs as well as business development and alliance management. Jane has worked in Australia, the United States and United Kingdom. Throughout her career, she has led many fundraising campaigns and licensing. He is a Non-Executive Director of Anatara Lifesciences Ltd and Bionomics Ltd. She is a Member of Risk Committee.
|
Mr Mark Andrew Licciardo | Company Secretary | Oct 2022 |
-
|
Mr Paul Joseph Mcdonald | Chief Executive Officer | Sep 2022 |
-
|
Dr David Sparling | Joint Company Secretary | Feb 2018 |
-
|
Ms Ancila Desai | Chief Financial OfficerJoint Company Secretary | Jun 2020 |
-
|
Paul Joseph Mcdonald | Chief Executive Officer |
-
|
|
Ancila Desai | Chief Financial OfficerJoint Company Secretary |
-
|
|
Mark Andrew Licciardo | Company Secretary |
-
|
|
David Sparling | Joint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
One Managed Invt Funds Ltd and Sandon Capital Inv Ltd A/C | 32,408,366 | 8.19% |
Merrill Lynch (Australia) Nominees Pty Limited | 23,682,196 | 5.98% |
HSBC Custody Nominees (Australia) Limited | 23,554,937 | 5.95% |
One Fund Services Ltd and Sandon Capital Inv Ltd A/C | 18,933,201 | 4.78% |
Ubs Nominees Pty Ltd | 13,755,534 | 3.47% |
Citicorp Nominees Pty Limited | 9,978,904 | 2.52% |
Mr Anthony John Huntley | 9,690,316 | 2.45% |
Invia Custodian Pty Limited and Graeme Leslie Blackman A/C | 6,029,710 | 1.52% |
Keiser Investments Pty Ltd and Gann Family Retirement A/C | 5,502,672 | 1.39% |
Picherit'S Farm Pty Ltd and Huntley Super Fund A/C | 5,280,723 | 1.33% |
Mr Robert Darius Fraser and Fraser Family A/C | 3,990,331 | 1.01% |
Invia Custodian Pty Limited and Paulene Blackman A/C | 3,457,737 | 0.87% |
Buttonwood Nominees Pty Ltd | 3,000,000 | 0.76% |
Ms Melissa Mary Stephens | 2,961,539 | 0.75% |
Warbont Nominees Pty Ltd and Unpaid Entrepot A/C | 2,650,752 | 0.67% |
Paul Mcdonald | 2,616,539 | 0.66% |
On On For Don Pty Ltd and Mac Family A/C | 2,461,539 | 0.62% |
Neweconomy Com Au Nominees Pty Limited and 900 Account | 2,373,299 | 0.60% |
Mr Alistair David Strong | 2,153,847 | 0.54% |
Tide Rider Pty Ltd | 2,086,539 | 0.53% |